IRCT20220803055607N1Recruiting
The effect of sitagliptin and metformin on the quality of oocyte and embryos, the number of retrieved oocyte
Comparison of the effect of sitagliptin and metformin on oocyte and embryo quality, number of retrieved and fertilized oocyte and embryo the Polycystic ovary syndrome (PCOS) insulin-resistant women undergoing In vitro fertilization (IVF)
Babol University of Medical SciencesPhase 3Iranian Registry Of Clinical Trialdrug
VerifiedIranian Registry Of Clinical Trial
Study focus
- Disease/Condition
- Polycystic ovarian syndrome
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Babol University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 3
- Start date
- Aug 13, 2022
- End date
- N/A
ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionOther and unspecified ovarian cysts
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20220803055607N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20220803055607N1 through Pure Global AI's free database. This Phase 3 trial is sponsored by Babol University of Medical Sciences and is currently Recruiting. The study focuses on Polycystic ovarian syndrome.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.